88. Clinical impact of targeted genomic profiling

Next-generation sequencing (NGS) assays for solid tumors range from those that assess dozens of genes with actionable clinical utility (targeted genomic profiling, TGP) to assays that evaluate hundreds of genes (comprehensive genomic profiling, CGP). Genes included in TGP are limited in number and carefully chosen based on their clinical actionability with prognostic and/or therapeutic impact. Our goal is to determine the degree of difference in clinical impact of TGP as compared with CGP.We analyzed 775 unique CGP cases.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Source Type: research